NOTICE TO THE MEDIA - Government of Canada officials to hold a technical briefing on Monkeypox in Canada
OTTAWA, ON, July 26, 2022 /CNW/ - Government of Canada officials will provide an update on Monkeypox in Canada.
Participants will be available to answer questions from the media following their remarks.
Date July 27, 2022
Time 1:00 PM (EDT)
Location
The news conference will be virtual only.
Participation in the question and answer portion of this event is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact [email protected] for temporary access.
A teleconference line is also available for listening to the event:
Toll-free dial-in number (Canada/US): 1-866-206-0153
Local dial-in number: 613-954-9003
Participant passcode: 8369588
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community. Aspire Health experienced a data security incident that may have involved personal and...
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...
Summary
Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...
